This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Edwards Lifesciences Corp (EW)

NYSE: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 420.40M 310.90M 171.20M 396.10M
Receivables 328.00M 347.50M 320.70M 302.50M
Inventories 308.90M 281.00M 261.30M 203.60M
Other Current Assets 118.60M 98.60M 57.10M 43.10M
Total Current Assets 1.73B 1.29B 1.17B 1.03B
Property, Plant & Equipment, Gross 764.70M 694.50M 604.10M 542.40M
Accumulated Depreciation & Depletion 343.10M 321.20M 299.80M 272.60M
Property, Plant & Equipment, Net 421.60M 373.30M 304.30M 269.80M
Intangibles 57.20M 67.00M 66.90M 67.10M
Other Non-Current Assets 64.60M 57.30M 71.00M 38.00M
Total Non-Current Assets 998.90M 929.60M 812.00M 734.60M
Liabilities & Shareholder Equity
Total Assets 2.72B 2.22B 1.98B 1.77B
Accounts Payable 48.40M 74.70M 85.00M 47.60M
Short Term Debt 0.00 0.00 0.00 41.80M
Other Current Liabilities 0.00 40.50M 37.50M 22.30M
Total Current Liabilities 345.60M 347.40M 335.20M 337.80M
Long Term Debt 593.10M 189.30M 150.40M 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 226.80M 205.50M 157.00M 121.20M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 819.90M 394.80M 307.40M 121.20M
Total Liabilities 1.17B 742.20M 642.60M 459.00M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 1.56B 1.48B 1.34B 1.31B
Common Par 126.00M 124.20M 120.00M 117.00M
Additional Paid In Capital 671.20M 489.00M 300.50M 211.30M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 2.05B 1.65B 1.36B 1.12B
Treasury Stock -1.26B -749.90M -405.80M -102.00M
Other Equity Adjustments -27.60M -37.90M -37.50M -42.10M
Total Capitalization 2.15B 1.67B 1.49B 1.31B
Total Equity 1.56B 1.48B 1.34B 1.31B
Total Liabilities & Stock Equity 2.72B 2.22B 1.98B 1.77B
Total Common Shares Outstanding 109.30M 114.30M 114.10M 115.00M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 16.70M 9.90M 5.90M 2.00M
Basic Weighted Shares Outstanding 111.70M 114.90M 114.60M 113.70M
Diluted Weighted Shares Outstanding 113.80M 118.30M 119.40M 119.20M
Number of Employees 8600 8200 7800 7000
Number of Part-Time Employees 0 0 0 0
EW News

EW Edwards Lifesciences Corp

Analysts Ratings for EW

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 9 10 10 11
Moderate Buy 0 0 0 0
Hold 8 7 7 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

EW Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs